T1	Participants 165 226	Cooperative Group of Study and Treatment of Multiple Myeloma.
T2	Participants 475 549	Patients with untreated stage I MM (defined according to Durie and Salmon)
T3	Participants 721 738	stage II patients
T4	Participants 777 795	stage III patients
